What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His main research concerns Internal medicine, Cancer, Oncology, Cancer research and Pathology.
His Internal medicine research includes elements of Gastroenterology, Surgery and Isotretinoin.
His biological study spans a wide range of topics, including Prospective cohort study, Physical therapy, Immunology and Disease.
His work deals with themes such as Survival rate and Clinical endpoint, Clinical trial, Phases of clinical research, which intersect with Oncology.
His Cancer research research integrates issues from Carcinogenesis, Gene, Mutation, Retinoic acid receptor and Receptor.
His work deals with themes such as Sentinel lymph node, Head and neck cancer, Apoptosis and Cutaneous melanoma, which intersect with Pathology.
His most cited work include:
- Comprehensive genomic characterization of head and neck squamous cell carcinomas (1933 citations)
- PROSTATE CANCER RADIATION DOSE RESPONSE: RESULTS OF THE M. D. ANDERSON PHASE III RANDOMIZED TRIAL (1206 citations)
- Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. (1091 citations)
What are the main themes of his work throughout his whole career to date?
J. Jack Lee spends much of his time researching Internal medicine, Oncology, Cancer, Lung cancer and Cancer research.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Surgery and Pathology.
His Oncology study combines topics from a wide range of disciplines, such as Head and neck squamous-cell carcinoma, Head and neck cancer, Phases of clinical research, Clinical endpoint and Biomarker.
His Cancer research incorporates themes from Radiation therapy, Proportional hazards model and Bioinformatics.
His Lung cancer research is multidisciplinary, incorporating elements of Targeted therapy, KRAS, Lung and Adenocarcinoma.
J. Jack Lee interconnects Carcinogenesis, Cancer cell, Mutation, Immunology and Receptor in the investigation of issues within Cancer research.
He most often published in these fields:
- Internal medicine (44.19%)
- Oncology (32.72%)
- Cancer (29.36%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (44.19%)
- Oncology (32.72%)
- Cancer research (20.03%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Oncology, Cancer research, Clinical trial and Lung cancer.
His Oncology study integrates concerns from other disciplines, such as Head and neck squamous-cell carcinoma, Carcinoma, Cohort and Immunotherapy.
His research integrates issues of Immunohistochemistry, T cell, Immune system, Transcriptome and Adenocarcinoma in his study of Cancer research.
His Clinical trial research includes themes of MEDLINE, Randomized controlled trial, Bayesian probability, Artificial intelligence and Machine learning.
The various areas that J. Jack Lee examines in his Lung cancer study include Cell, Ipilimumab, Genotype and Confidence interval.
His research in Cancer intersects with topics in Placebo and Adverse effect.
Between 2018 and 2021, his most popular works were:
- Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. (286 citations)
- Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study (144 citations)
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial. (137 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
J. Jack Lee mainly investigates Internal medicine, Oncology, Clinical trial, Lung cancer and Cancer.
His work carried out in the field of Oncology brings together such families of science as Nivolumab, Immune checkpoint inhibitors, Immunotherapy and Cohort.
He combines subjects such as Adverse effect, Randomized controlled trial, Drug development and Hazard ratio with his study of Clinical trial.
J. Jack Lee has included themes like Carcinoma, Lung and Immune system in his Lung cancer study.
His studies deal with areas such as Survival rate and Gemcitabine as well as Carcinoma.
His study in Immune system is interdisciplinary in nature, drawing from both Immunohistochemistry, Cancer research and Serology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
